{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/02/3267226/0/en/Skye-Bioscience-Treats-First-Patient-in-Nimacimab-Higher-Dose-Expansion-Study-Evaluating-Exposure-Response-to-Inform-Phase-2b-Dose-Selection-for-GLP-1-Combination-Development.html", "message": "News view counter 641935 successfully enlarged"}